# Perioperative Fluid Management: Goal-directed Versus Restrictive Strategy

Study · id `cardio:ct-nct02625701` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02625701](<https://clinicaltrials.gov/study/NCT02625701>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02625701

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Heart rhythm problems; Heart failure; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 400 participants.

## Technical summary

Registry record NCT02625701. Randomized; single masking; primary purpose prevention. Start 2012-01 (registry gives no type); primary completion 2019-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT02625701, source copy `cardio:ctgov-nct02625701-2019-09-12`, retrieved 2026-10-26)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT02625701, source copy `cardio:ctgov-nct02625701-2019-09-12`, retrieved 2026-10-26)
- Primary completion: 2019-09 (actual) (ClinicalTrials.gov record NCT02625701, source copy `cardio:ctgov-nct02625701-2019-09-12`, retrieved 2026-10-26)
- Completion: 2019-09 (actual) (ClinicalTrials.gov record NCT02625701, source copy `cardio:ctgov-nct02625701-2019-09-12`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT02625701, source copy `cardio:ctgov-nct02625701-2019-09-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02625701-2019-09-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Perioperative Fluid Management: Goal-directed Versus Restrictive Strategy
- Condition: Complication, Postoperative
- Intervention (Procedure): Goal-directed therapy
- Intervention (Procedure): Restrictive fluid therapy
- Lead sponsor: University Hospital, Geneva
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University Hospital, Geneva (`cardio:org-university-hospital-geneva`)

## Provenance

Content hash: a836c65404683ffd207c8539dead13304b1126a2fe71b45d5a0798dfff4519a0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
